These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 14985787

  • 1. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y, Ishii K, Hisaeda H, Hamano S, Zhang M, Nakanishi K, Yoshimoto T, Hemmi H, Takeda K, Akira S, Iwakura Y, Himeno K.
    Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
    [Abstract] [Full Text] [Related]

  • 2. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
    Gabaglia CR, Pedersen B, Hitt M, Burdin N, Sercarz EE, Graham FL, Gauldie J, Braciak TA.
    J Immunol; 1999 Jan 15; 162(2):753-60. PubMed ID: 9916695
    [Abstract] [Full Text] [Related]

  • 3. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, Seegmüller I, Voigt H, Launois P, Levine AD, Wagner H, Heeg K, Louis JA, Röcken M.
    Nat Immunol; 2001 Nov 15; 2(11):1054-60. PubMed ID: 11600887
    [Abstract] [Full Text] [Related]

  • 4. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
    Zimmermann S, Egeter O, Hausmann S, Lipford GB, Röcken M, Wagner H, Heeg K.
    J Immunol; 1998 Apr 15; 160(8):3627-30. PubMed ID: 9558060
    [Abstract] [Full Text] [Related]

  • 5. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J, Schleicher U, Bogdan C.
    Eur J Immunol; 2007 Dec 15; 37(12):3424-34. PubMed ID: 18034422
    [Abstract] [Full Text] [Related]

  • 6. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
    Wakil AE, Wang ZE, Locksley RM.
    Exp Parasitol; 1996 Nov 15; 84(2):214-22. PubMed ID: 8932771
    [Abstract] [Full Text] [Related]

  • 7. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG, Kaser SB, Beller DI.
    J Immunol; 1998 Dec 15; 161(12):6878-84. PubMed ID: 9862720
    [Abstract] [Full Text] [Related]

  • 8. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD, Asada H, Jin ML, Kishida T, Shin-Ya M, Nakaya T, Kita M, Ishii M, Iwai M, Okanoue T, Imanishi J, Mazda O.
    Gene Ther; 2005 Jan 15; 12(2):160-8. PubMed ID: 15470476
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
    Kropf P, Etges R, Schopf L, Chung C, Sypek J, Müller I.
    J Immunol; 1997 Oct 01; 159(7):3434-43. PubMed ID: 9317142
    [Abstract] [Full Text] [Related]

  • 12. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
    Zhang X, Munegowda MA, Yuan J, Wei Y, Xiang J.
    J Leukoc Biol; 2010 Aug 01; 88(2):393-403. PubMed ID: 20466823
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S, Carrión J, Anderson C, Alonso C, Sacks D, Soto M.
    Infect Immun; 2005 Sep 01; 73(9):5842-52. PubMed ID: 16113303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection.
    Satoskar AR, Stamm LM, Zhang X, Satoskar AA, Okano M, Terhorst C, David JR, Wang B.
    J Immunol; 1999 Jun 01; 162(11):6747-54. PubMed ID: 10352294
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IL-4 induces a Th2 response in Leishmania major-infected mice.
    Chatelain R, Varkila K, Coffman RL.
    J Immunol; 1992 Feb 15; 148(4):1182-7. PubMed ID: 1531351
    [Abstract] [Full Text] [Related]

  • 20. Cathepsin B-inhibitor promotes the development of Th1 type protective T cells in mice infected with Leishmania major.
    Maekawa Y, Himeno K, Katunuma N.
    J Med Invest; 1997 Aug 15; 44(1-2):33-9. PubMed ID: 9395715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.